Reaching a correct diagnosis in Endodontics can be as simple as placing a TFE saturated cotton on a suspect tooth and generating an unmistakeable response of either pulpal necrosis or symptomatic irreversible pulpitis. However, there are instances in which patients present with other non-odontogenic symptoms that mimic these common endodontic ailments that create
difficulties for practitioners.
Varicella Zoster Virus (VZV) specifically is a DNA envelope virus only found in humans. Herpes Zoster is 1 of a total of 9 distinct viruses of the herpesviridae family. Typically 8 herpesviruses, 8 normally infect only humans, of the more than 100 known; varicella-zoster virus, Herpes simplex virus types 1 and 2, cytomegalovirus, Epstein-Barr virus, human herpesvirus 7 (variants A and B), human herpesvirus 6, and human herpesvirus 8 (KS). A simian virus, called B virus, is also capable of infecting humans. All herpesviruses are effective at establishing latent infection within specific tissues, which are attributes for each virus. Herpesviruses have a unique four-layered structure: a core containing the large, double-stranded DNA genome is enclosed by a polyhedron capsid which is composed of capsomeres. A glycoprotein-bearing lipid bilayer envelope cases the capsid which is encircled by a tegument, which is simply an amorphous protein. With respect to varicella zoster virus (VZV), most patients that typically have this virus were infected at some earlier point in their life. Normally after the virus accomplishes primary infection, it then continues dormant within the neural tissues, more specifically, ganglia tissue. Additional flare ups of herpes zoster typically surface after several years of latency, many times decades, when humans develop immunodeficiencies. From and epidemiological standpoint, roughly over 1 million incidents of herpes zoster occur on an annual bases in the United States with a lifetime risk that has been calculated to be as much as 10%–20%. Immunosuppression, alcohol abuse, older age, radiation, treatment with any cytotoxic drugs, malignancies, and dental treatment are all potential risk factors for worsening of symptoms.
Most people usually experience only one incidence of herpes zoster in their entire lifetime although recurrent episodes are not uncommon. A cohort study compared the incidence of herpes zoster recurrence between immunocompetent adults aged greater than or equal to 60 years who were or were not vaccinated following an episode of herpes zoster. It is hypothesized that the incidence of herpes zoster is associated with a reduction below an unknown, conceivably host-specific, threshold level of varicella zoster virus (VZV)–specific cell-mediated immunity. The data from this study supported that recurrences of herpes zoster are relatively uncommon in immunocompetent persons. The vaccinated group did show a lower incidence of recurrent episodes but the overall data when considered did not show a definitive benefit to have patients receive a vaccine. However, the current Advisory Committee Immunization Practices (ACIP) is recommending scheduled vaccination of all people 60 years or older with 1 dose of zoster vaccine. There is also no contraindication for people with a who report a previous episode of zoster and persons with chronic medical conditions (e.g., chronic renal failure, diabetes mellitus, rheumatoid arthritis, and chronic pulmonary disease) can be vaccinated unless those conditions are contraindications or precautionsIt has the potential to affect any sensory ganglion and its associated nerve, commonly affecting more cranial nerve dermatomes than other thoracic and abdominal. The disease typically manifests by the appearance of a rash consisting of macules/papules in neighboring dermatomes, which usually maintain and ipsilateral disturbution. The rash progresses into painful clusters of vesicles that proceed to form over approximately 4 days and eventually a dry crust over a couple of weeks to a month later. Incidence of the disease in immunocompromised individuals results in a rash that may affect 3 or more dermatomes. Usually with maxillofacial active states, the trigeminal nerve (CN V) is the most common cranial nerve associated (approximately 20% of cases) followed by the glossopharyngeal (CN IX) and hypoglossal nerve (CN XII) (8) .
For cases involving the trigeminal (CN V), herpes zoster usually affects sections associated with the different branches and their respective dermatones; ophthalmic (V1) (9) , maxillary nerve (V2) (10) , and the mandibular nerve (V3) (11). Sometimes multiple dermatomes may be affected simultaneously regardless of immunocompetence (12) . Most often reported involvement is the ophthalmic V1 dermatome, with the V2 and V3 dermatomes usually less commonly involved (13) .
Interestingly enough herpes zoster may present initially as odontogenic pain. This possible odontalgia presenting as pulpitis is challenging during the prodromal stage of the disease for many physicians and dentist as it can be masked prior to the eruption of vesicles and rash (14–16) . Sometimes a differential diagnosis of orofacial pain associated with the trigeminal nerve may be further complicated by zoster sine herpete, which is basically the absence of clinically visible signs and symptoms, such as a vesicular rash during the active stage of the disease. The active stage associated with the emergence of rash accompanied by generalized malaise, headache, low grade fever and sometimes nausea. (17) . In this condition, dentist or physicians should typically suspect possible virological involvement and request serological testing for varicella zoster virus deoxyribonucleic acid or anti-varicella zoster virus antibodies in the serum or cerebrospinal fluid to establish a proper diagnosis as apposed to proceeding with unnecessary dental treatment such as root canal therapy (18) .
Some patients may experience the pain associated with herpes zoster of the trigeminal nerve for months to even years after the physical signs and symptoms have has resolved. This resulting painful condition, post herpes zoster, is known as postherpetic neuralgia, and it happens to be the most common post-infectious ailment of herpes zoster (19) . Myelitis, meningoencephalitis, and VZV vasculopathy are possible concomitant complications of varicella zoster virus reactivation in herpes zoster (20) . Therefore, cerebral infarction and stroke are possible delayed risks for patients with herpes zoster involving any trigeminal division. (10, 21, 22) . As far as endodontics is concern, pulpal or periapical pathosis associated with herpes zoster of the orofacial region have been reported during the course of the disease with (23–26) debatable reasons of how the 2 sequelae are linked (15) . More specially, case reports in the literature of multiple devitalization of four of five teeth in left maxillary quadrant in a 70-year-old woman with a history of herpes zoster infection affecting maxillary branch of the trigeminal nerve. In additions, reports non-vital teeth affecting entire left maxillary dentition except central incisor who suffered 8 years earlier herpes zoster involving maxillary division of the trigeminal nerve on the left side. External or internal root resorption, osteonecrosis of the jaw, and spontaneous exfoliation of teeth have been describe as other possible dental complications.
The above images demonstrate a case reported in the endodontic literature by Paquin et al. This case report sheds additional light on the possible concomitant manifestations of herpes zoster. The patient that presented with a “shooting pain” radiating to his upper lip and right eye pain which began 5 days before his appointment. Right Maxillary canine was diagnosed with pulp necrosis and symptomatic apical periodontitis was made. A few days post endodontic therapy, clinical signs and symptoms of herpes zoster began to manifest.